Chloropyramine Hydrochloride

盐酸氯吡拉敏

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameChloropyramine Hydrochloride

Drug Alias NameFAK inhibitors - CureFAKtor氯吡胺盐酸盐FAK technology platform - CureFAKtor盐酸氯吡胺chloropyraminum +[19]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistamine H1 receptor antagonistsVascular endothelial growth factor receptor 3 antagonistsFocal adhesion kinase inhibitors

TargetsHistamine H1 receptorFocal adhesion kinaseVascular endothelial growth factor receptor 3

Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, AllergicAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsConjunctivitis, AllergicRhinitis, AllergicAsthma

Inactive IndicationsN/A

ATC CodeD04AA09R06AC03